Bal Pharma has informed that a meeting of the Board of Directors of the Company will be held on August 11, 2014 inter alia, for considering Un-Audited Financial results for the quarter ended June 30, 2014, proposal for preferential issue of securities will also be taken up for consideration by the Board at the said meeting.
The above information is a part of company’s filings submitted to BSE